budesonide inhalation
budesonide inhalation is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand name including budesonide inhalation. Available dosage form: suspension.
Drug Details
- Generic Name
- budesonide inhalation
- Brand Names
- budesonide inhalation
- Application Number
- ANDA210897
- Sponsor
- Lupin Pharmaceuticals, Inc.
- NDC Codes
- 3
- Dosage Forms
- SUSPENSION
- Routes
- RESPIRATORY (INHALATION)
- Active Ingredients
- BUDESONIDE
Indications and Usage
1 INDICATIONS AND USAGE Budesonide inhalation suspension is an inhaled corticosteroid indicated for: Maintenance treatment of asthma and as prophylactic therapy in children 12 months to 8 years of age ( 1 ) Limitations of Use: Not indicated for the relief of acute bronchospasm ( 1 ) 1.1 Maintenance Treatment of Asthma Budesonide inhalation suspension is indicated for the maintenance treatment of asthma and as prophylactic therapy in children 12 months to 8 years of age. Limitations of Use: Budesonide inhalation suspension is NOT indicated for the relief of acute bronchospasm.